Compartment-specific gene regulation of the CAR inducer efavirenz in vivo

H. E. Meyer Zu Schwabedissen, S. Oswald, C. Bresser, A. Nassif, C. Modess, Zeruesenay Desta, E. T. Ogburn, M. Marinova, D. Lütjohann, C. Spielhagen, M. Nauck, H. K. Kroemer, W. Siegmund

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Nuclear receptors such as the constitutive androstane receptor (CAR) are central factors that link drug exposure to the activities of drug metabolism and elimination. In order to determine the in vivo effects of efavirenz, a CAR activator, the expression of target genes was determined in duodenal biopsies obtained from 12 healthy volunteers before treatment and after 10 days of treatment with efavirenz; concomitant administration of the cholesterol inhibitor ezetimibe produced no significant difference. However, in in vitro studies, efavirenz significantly increased CYP2B6 expression in several cell types, suggesting that the drug transactivates CAR. This hypothesis is supported by our findings that there is significant induction of CAR target genes in in vivo peripheral blood mononuclear cells (PBMCs) isolated from healthy volunteers treated with multiple doses of efavirenz. The impact of efavirenz on hepatic metabolism in vivo was confirmed by significant changes in plasma 4β-hydroxycholesterol and bilirubin levels and the area under the curve (AUC) of efavirenz. Induction of CYP2B6 mRNA expression correlated with the decrease in the AUC of efavirenz (r = 0.61; P = 0.036). Taken together, our results provide evidence that efavirenz exerts compartment-specific inductive capacity in vivo.

Original languageEnglish
Pages (from-to)103-111
Number of pages9
JournalClinical Pharmacology and Therapeutics
Volume92
Issue number1
DOIs
StatePublished - Jul 2012

Fingerprint

efavirenz
Genes
Area Under Curve
Healthy Volunteers
Pharmaceutical Preparations
Anticholesteremic Agents
constitutive androstane receptor
Cytoplasmic and Nuclear Receptors
Bilirubin

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Meyer Zu Schwabedissen, H. E., Oswald, S., Bresser, C., Nassif, A., Modess, C., Desta, Z., ... Siegmund, W. (2012). Compartment-specific gene regulation of the CAR inducer efavirenz in vivo. Clinical Pharmacology and Therapeutics, 92(1), 103-111. https://doi.org/10.1038/clpt.2012.34

Compartment-specific gene regulation of the CAR inducer efavirenz in vivo. / Meyer Zu Schwabedissen, H. E.; Oswald, S.; Bresser, C.; Nassif, A.; Modess, C.; Desta, Zeruesenay; Ogburn, E. T.; Marinova, M.; Lütjohann, D.; Spielhagen, C.; Nauck, M.; Kroemer, H. K.; Siegmund, W.

In: Clinical Pharmacology and Therapeutics, Vol. 92, No. 1, 07.2012, p. 103-111.

Research output: Contribution to journalArticle

Meyer Zu Schwabedissen, HE, Oswald, S, Bresser, C, Nassif, A, Modess, C, Desta, Z, Ogburn, ET, Marinova, M, Lütjohann, D, Spielhagen, C, Nauck, M, Kroemer, HK & Siegmund, W 2012, 'Compartment-specific gene regulation of the CAR inducer efavirenz in vivo', Clinical Pharmacology and Therapeutics, vol. 92, no. 1, pp. 103-111. https://doi.org/10.1038/clpt.2012.34
Meyer Zu Schwabedissen, H. E. ; Oswald, S. ; Bresser, C. ; Nassif, A. ; Modess, C. ; Desta, Zeruesenay ; Ogburn, E. T. ; Marinova, M. ; Lütjohann, D. ; Spielhagen, C. ; Nauck, M. ; Kroemer, H. K. ; Siegmund, W. / Compartment-specific gene regulation of the CAR inducer efavirenz in vivo. In: Clinical Pharmacology and Therapeutics. 2012 ; Vol. 92, No. 1. pp. 103-111.
@article{952dc3217b36459b9b5c995b89240226,
title = "Compartment-specific gene regulation of the CAR inducer efavirenz in vivo",
abstract = "Nuclear receptors such as the constitutive androstane receptor (CAR) are central factors that link drug exposure to the activities of drug metabolism and elimination. In order to determine the in vivo effects of efavirenz, a CAR activator, the expression of target genes was determined in duodenal biopsies obtained from 12 healthy volunteers before treatment and after 10 days of treatment with efavirenz; concomitant administration of the cholesterol inhibitor ezetimibe produced no significant difference. However, in in vitro studies, efavirenz significantly increased CYP2B6 expression in several cell types, suggesting that the drug transactivates CAR. This hypothesis is supported by our findings that there is significant induction of CAR target genes in in vivo peripheral blood mononuclear cells (PBMCs) isolated from healthy volunteers treated with multiple doses of efavirenz. The impact of efavirenz on hepatic metabolism in vivo was confirmed by significant changes in plasma 4β-hydroxycholesterol and bilirubin levels and the area under the curve (AUC) of efavirenz. Induction of CYP2B6 mRNA expression correlated with the decrease in the AUC of efavirenz (r = 0.61; P = 0.036). Taken together, our results provide evidence that efavirenz exerts compartment-specific inductive capacity in vivo.",
author = "{Meyer Zu Schwabedissen}, {H. E.} and S. Oswald and C. Bresser and A. Nassif and C. Modess and Zeruesenay Desta and Ogburn, {E. T.} and M. Marinova and D. L{\"u}tjohann and C. Spielhagen and M. Nauck and Kroemer, {H. K.} and W. Siegmund",
year = "2012",
month = "7",
doi = "10.1038/clpt.2012.34",
language = "English",
volume = "92",
pages = "103--111",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Compartment-specific gene regulation of the CAR inducer efavirenz in vivo

AU - Meyer Zu Schwabedissen, H. E.

AU - Oswald, S.

AU - Bresser, C.

AU - Nassif, A.

AU - Modess, C.

AU - Desta, Zeruesenay

AU - Ogburn, E. T.

AU - Marinova, M.

AU - Lütjohann, D.

AU - Spielhagen, C.

AU - Nauck, M.

AU - Kroemer, H. K.

AU - Siegmund, W.

PY - 2012/7

Y1 - 2012/7

N2 - Nuclear receptors such as the constitutive androstane receptor (CAR) are central factors that link drug exposure to the activities of drug metabolism and elimination. In order to determine the in vivo effects of efavirenz, a CAR activator, the expression of target genes was determined in duodenal biopsies obtained from 12 healthy volunteers before treatment and after 10 days of treatment with efavirenz; concomitant administration of the cholesterol inhibitor ezetimibe produced no significant difference. However, in in vitro studies, efavirenz significantly increased CYP2B6 expression in several cell types, suggesting that the drug transactivates CAR. This hypothesis is supported by our findings that there is significant induction of CAR target genes in in vivo peripheral blood mononuclear cells (PBMCs) isolated from healthy volunteers treated with multiple doses of efavirenz. The impact of efavirenz on hepatic metabolism in vivo was confirmed by significant changes in plasma 4β-hydroxycholesterol and bilirubin levels and the area under the curve (AUC) of efavirenz. Induction of CYP2B6 mRNA expression correlated with the decrease in the AUC of efavirenz (r = 0.61; P = 0.036). Taken together, our results provide evidence that efavirenz exerts compartment-specific inductive capacity in vivo.

AB - Nuclear receptors such as the constitutive androstane receptor (CAR) are central factors that link drug exposure to the activities of drug metabolism and elimination. In order to determine the in vivo effects of efavirenz, a CAR activator, the expression of target genes was determined in duodenal biopsies obtained from 12 healthy volunteers before treatment and after 10 days of treatment with efavirenz; concomitant administration of the cholesterol inhibitor ezetimibe produced no significant difference. However, in in vitro studies, efavirenz significantly increased CYP2B6 expression in several cell types, suggesting that the drug transactivates CAR. This hypothesis is supported by our findings that there is significant induction of CAR target genes in in vivo peripheral blood mononuclear cells (PBMCs) isolated from healthy volunteers treated with multiple doses of efavirenz. The impact of efavirenz on hepatic metabolism in vivo was confirmed by significant changes in plasma 4β-hydroxycholesterol and bilirubin levels and the area under the curve (AUC) of efavirenz. Induction of CYP2B6 mRNA expression correlated with the decrease in the AUC of efavirenz (r = 0.61; P = 0.036). Taken together, our results provide evidence that efavirenz exerts compartment-specific inductive capacity in vivo.

UR - http://www.scopus.com/inward/record.url?scp=84862591111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862591111&partnerID=8YFLogxK

U2 - 10.1038/clpt.2012.34

DO - 10.1038/clpt.2012.34

M3 - Article

VL - 92

SP - 103

EP - 111

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -